Ingersoll Rand's fundamental outlook rests on a light-asset industrial model in which operating cash flow has run roughly 1.0 to 2.3 times net income in most recent quarters, with capital expenditures held at 1.2% to 2.0% of revenue.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth has settled into a 5.6% to 8.5% band while gross margin swung between roughly 24% and 45% and operating margin between 4.0% and 37.9%, suggesting cost timing and mix effects rather than a structural shift in pricing power.
Ingersoll Rand reported year-on-year increases in quarterly sales and earnings, alongside lower impairment charges, indicating robust financial health.
The company confirmed 2026 revenue growth guidance of 2.5% to 4.5%, signaling confidence in future performance.
Ingersoll Rand's upcoming participation in an investor conference highlights its commitment to engaging with the investment community.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 29, 2026 | $1.07+18.5% vs $0.90 | $2.1B+0.6% vs $2.1B |
Q3 2026 Jul 30, 2026 | $0.86+4.0% vs $0.83 | $2.0B+4.7% vs $2.0B |
Q2 2026 Apr 28, 2026 | $0.77+4.1% vs $0.74 | $1.8B+0.9% vs $1.8B |
Q1 2026 Feb 12, 2026 | $0.96+5.8% vs $0.91 | $2.1B+2.3% vs $2.0B |
International Assets Investment Management LLC boosted its position in shares of Ingersoll Rand Inc. (NYSE: IR) by 712.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 28,745 shares of the industrial products company's stock after acquiring an
DAVIDSON, N.C.--(BUSINESS WIRE)-- #MakingLifeBetter--Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and life science and industrial solutions, has acquired IVEK Corporation, expanding the company's life sciences portfolio. Based in the United States, IVEK is a leading designer and manufacturer of small-volume precision liquid metering and dispensing systems with expertise in precision fluid control, primarily serving the healthcare, diagnostics, medical device and biomedical in.
Ingersoll Rand NYSE: IR reported third-quarter 2026 results marked by accelerating order growth, higher revenue and adjusted earnings per share, while raising its full-year revenue and adjusted EPS outlook. The company also highlighted a large engineered-to-order data center infrastructure contract, expanded its share repurchase authorization and closed an acquisition in its Precision and Science Technologies segment.
Ingersoll Rand Inc. ( IR ) Q3 2026 Earnings Call October 30, 2026 8:00 AM EDT Company Participants Max Vorcheimer - Executive Officer of Investor Relations Vicente Reynal - Chairman, CEO & President Vikram Kini - Senior VP & CFO Conference Call Participants Michael Halloran - Robert W. Baird & Co. Incorporated, Research Division Nigel Coe - Wolfe Research, LLC Stephen Volkmann - Jefferies LLC, Research Division Robert Wertheimer - Melius Research LLC Nathan Jones - Stifel, Nicolaus & Company, Incorporated, Research Division Joseph O'Dea - Vertical Research Partners, LLC Joseph Ritchie - Goldman Sachs Group, Inc., Research Division Andrew Kaplowitz - Citigroup Inc., Research Division Nicole DeBlase - Deutsche Bank AG, Research Division Amit Mehrotra - UBS Investment Bank, Research Division David Raso - Evercore ISI Institutional Equities, Research Division Brandon Knutson - Morgan Stanley, Research Division Presentation Operator Hello, everyone.
Benchmark IR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Ingersoll Rand Inc. (IR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $82.99 | $32.48B | 23.26 | 5.75% | 17.2% | 13.44% | 0.1% | |
| $226.99 | $16.73B | 31.35 | 5.77% | 14.65% | 13.31% | 1.24% | |
| $97.83 | $22.84B | 21.23 | 5.52% | 11.86% | 9.78% | 1.64% | |
| $476.60 | $48.1B | 18.29 | 12.26% | 30.71% | 13.53% | 0.69% | |
| $68.12 | $11.01B | 17.84 | 2.28% | 15.44% | 16.02% | 1.46% | |
| $94.17 | $4.16B | 21.16 | 5.44% | 8.83% | 14.46% | 1.17% |
Ingersoll Rand Inc. (IR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Ingersoll Rand Inc. (IR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 30, 2026·SEC
Oct 29, 2026·SEC
Jul 30, 2026·SEC
Get notified when IR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Ingersoll Rand Inc. (IR) stock FAQ — growth, dividends, profitability & financials explained
Ingersoll Rand Inc. (IR) reported $8.05B in revenue over the trailing twelve months. Revenue was $7.65B in fiscal year 2025. That is 225% more than the $2.36B of fiscal year 2012.
Ingersoll Rand Inc. (IR) grew revenue by 8.0% over the trailing twelve months, compared with the twelve months before.
Yes. Ingersoll Rand Inc. (IR) earned $1.38B in net income over the trailing twelve months (a 17.2% net margin).
Ingersoll Rand Inc. (IR) does not currently pay a meaningful dividend.
Ingersoll Rand Inc. (IR) had a return on equity (ROE) of 13.4% over the trailing twelve months. That is in line with the market's typical 10-15%.
Ingersoll Rand Inc. (IR) generated $1.52B in free cash flow over the trailing twelve months.
